Boron-containing small molecules as anti-inflammatory agents

Details Boron-containing small molecules as anti-inflammatory agents Boron-containing small molecules as anti-inflammatory agents

2009-03-05

2011-10-18

Aulakh, Charanjit (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Boron containing doai

C558S288000, C546S284100, C546S290000

Reexamination Certificate

active

08039450

ABSTRACT:
Compounds and methods of treating anti-inflammatory conditions are disclosed.

REFERENCES:
patent: 2260336 (1941-10-01), Prescott et al.
patent: 3873279 (1975-03-01), Singer
patent: 4602011 (1986-07-01), West et al.
patent: 4716035 (1987-12-01), Sampathkumar
patent: 4766113 (1988-08-01), West et al.
patent: 4894220 (1990-01-01), Nabi et al.
patent: 5348947 (1994-09-01), Patel et al.
patent: 5348948 (1994-09-01), Patel et al.
patent: 5591731 (1997-01-01), Kennedy et al.
patent: 5668258 (1997-09-01), Stolowitz
patent: 5688928 (1997-11-01), Stolowitz
patent: 5831045 (1998-11-01), Stolowitz et al.
patent: 5880188 (1999-03-01), Austin et al.
patent: 5962498 (1999-10-01), Driedger et al.
patent: 6083903 (2000-07-01), Adams et al.
patent: 6306628 (2001-10-01), Rothschild et al.
patent: 6369098 (2002-04-01), Pershadsingh et al.
patent: 6521619 (2003-02-01), Link et al.
patent: 6800645 (2004-10-01), Cox et al.
patent: 6855848 (2005-02-01), Scherer et al.
patent: 7169603 (2007-01-01), Hedley et al.
patent: 7217701 (2007-05-01), Mikoshiba et al.
patent: 7390806 (2008-06-01), Lee et al.
patent: 7465836 (2008-12-01), Lee et al.
patent: 7582621 (2009-09-01), Baker et al.
patent: 7767657 (2010-08-01), Baker et al.
patent: 7816344 (2010-10-01), Baker et al.
patent: 2002/0028831 (2002-03-01), Manley
patent: 2002/0161230 (2002-10-01), Meudt et al.
patent: 2003/0032673 (2003-02-01), Nagy
patent: 2004/0077601 (2004-04-01), Adams et al.
patent: 2004/0224923 (2004-11-01), Lee et al.
patent: 2004/0259842 (2004-12-01), Mikoshiba et al.
patent: 2005/0054644 (2005-03-01), Lee et al.
patent: 2005/0125852 (2005-06-01), Caenepeel et al.
patent: 2005/0239170 (2005-10-01), Hedley et al.
patent: 2006/0009386 (2006-01-01), Stossel et al.
patent: 2006/0222671 (2006-10-01), Weidner
patent: 2006/0234981 (2006-10-01), Baker et al.
patent: 2007/0155699 (2007-07-01), Baker et al.
patent: 2007/0286822 (2007-12-01), Sanders et al.
patent: 2007/0293457 (2007-12-01), Baker et al.
patent: 2009/0227541 (2009-09-01), Baker et al.
patent: 2010/0256092 (2010-10-01), Xia et al.
patent: 0969531 (2000-01-01), None
patent: 1155698 (2001-11-01), None
patent: 1 444 981 (2004-08-01), None
patent: WO 9533754 (1995-05-01), None
patent: WO 9622023 (1996-07-01), None
patent: WO 9812206 (1998-03-01), None
patent: WO 0044387 (2000-08-01), None
patent: WO 0075142 (2000-12-01), None
patent: WO 0149303 (2001-07-01), None
patent: WO 0244184 (2002-06-01), None
patent: WO 03033002 (2003-04-01), None
patent: WO 03059916 (2003-07-01), None
patent: WO 2004056322 (2004-07-01), None
patent: WO 2005013892 (2005-02-01), None
patent: WO 2006007384 (2006-01-01), None
patent: WO 2006062731 (2006-06-01), None
patent: WO 2006079843 (2006-08-01), None
patent: WO 2006089067 (2006-08-01), None
patent: WO 2007022437 (2007-02-01), None
patent: WO 2007078340 (2007-07-01), None
patent: WO 2007095638 (2007-08-01), None
patent: WO 2007146965 (2007-12-01), None
patent: WO 2008157726 (2008-12-01), None
patent: WO 2009111676 (2009-09-01), None
patent: WO 2009014309 (2009-11-01), None
patent: WO 2010028005 (2010-03-01), None
patent: WO 2010045503 (2010-04-01), None
patent: WO 2010045505 (2010-04-01), None
Austin, et al., “Oxaboroles and Salts and their Use of Biocides for Plastics”, CAS, vol. 124, pp. 234-024, (1996).
Bailey, et al., “Boron-Containing Antibacterial Agents: Effects on Growth and Morphology of Bacteria Under Various Culture Conditions,” Antimicrobial Agents and Chemotherapy, 17(04):549-553, (Apr. 1980).
Baker, et al., “Discovery of New Boron-Containing Antifungal Agent, 5-Fluoro-1,3-dihydro-1-hydroxy-2, 1-benzoxaborole (AN2690) for Potential Treatment of Onychomoycosis”, Journal of Medicinal Chemistry, vol. 49, No. 15; pp. 4447-4450, (Jul. 27, 2006).
Brown, et al., “Chiral Synthesis Via Organoboranes. 35. Simple Procedures for the Efficient Recycling of the Terpenyl Chiral Auxiliaries and Convenient Isolation of the Homoallylic Alcohols in Asymmetric Allyl- and Crotylboration of Aldehydes,” J. Org. Chem., vol. 57, No. 24; pp. 6608-6614, (1992).
Cairns, et al., “Derivatives of 1,4-Xylene-2,5-diboronic acid and 1,4-xylene-2-boronic acid”, J. Org. Chem. vol. 29; pp. 2810-2812, (1964).
Chander, et al. “Prevalence of Fungal Corneal Ulcers in Northern India”, Infections, vol. 22, No. 3; pp. 207-209, (1994).
Chemical Abstracts Registry No. 845302-09-2, Entered STN Mar. 11, 2005.
Cui, et al., “Organoboron Compounds with an 8-Hydroxyquinolato Chelate and Its Derivatives: Substituent Effects on Structures and Luminescence,” Inorganic Chemistry, vol. 44, No. 03; pp. 601-609, (Feb. 7, 2005).
Dale, et al., “Substituted Styrenes VIII Syntheses and some Reactions of the Vinylbenzeneboronic Acids” J. Org. Chem. vol. 27; pp. 2598-2603, (1962).
Denis, “Pharmacology 1104 Lecture: Drug Classifications & Characteristics of Antimicrobials” (2003).
Farfan, et al., “Through-Bond Modulation on N-B Ring Formation Shown by NMR and X-Ray Diffraction Studies of Borate Derivatives of Pyridyl Alcohols,” J. Chem. Soc. Perkin Trans., vol. 2; pp. 527-532 (1992).
Ferrer, Targeting Aminocytl-tRNA Synthetases for the Treatment of Fungal Infections, Drug News Perspective, vol. 19, No. 6; pp. 347-348, (Jul./Aug. 2006).
Fungicide: Definition from Answer.com, (1998).
Grassberger, et al., “Degradation of 1,2-dihydro-1-hydroxy-2-(organosulfonyl)2,3,1-benzodiasaborines and -thieno[3,2-d][1,,3]diazaborines in Alkaline Aqueous Solutions”, Liebigs Annalen Der Chemie, vol. 4; pp. 683-688, (1985).
Guo-Zheng, et al., “Single Site Transarylation of 2,2′-Dimetalized-1,1′-Binaphthyl to Aminocloroborates and Synthesis of 2-Binaphthyl Boron Compounds,” Youji Huaxue/Organic Chemistry, Science Press, vol. 16, No. 02; pp. 139-144, (1996) (English Abstract).
Haynes, et al., “Arylboronic Acids VIII. Reactions of boronphthalide” J. Org. Chem. vol. 29, No. 11; pp. 3229-3233, (1964).
Hauck, et al., “Preparation and Anticonvulsant Activity of Some Arydialkkylsuccinimides” Research Lab of Parke Davis Co. (1967).
He, et al., “Small-Molecule Inhibition of TNF-alpha”, Science, vol. 310, No. 5750; pp. 1022-1025, (Nov. 11, 2005).
Lampe, et al., “Synthesis and Protein Kinase Inhibitory Activity of Balanol Analogues with Modified Benzophenone Subunits”, J. Med. Chem., vol. 45; pp. 2624-2643, (2002).
Lennarz, et al., “Arylboronic Acids. IV. Reactions of Boronophthalide” J. Am. Chem. Soc. vol. 82; pp. 2172-2175, (1960).
Li, et al., “An Improved Protocol for Preparation of 3-Pyridyl- and Some Arylboronic Acids”, J. Org. Chem., vol. 67; pp. 5394-5397, (2002).
Koster, et al., “Cyclisierugen von Bor-Stickstoff-Verbindugen in der Hietz” Liebigs Ann. Chem., vol. 720; pp. 23-31, (1968).
Koster, et al., “Boron Compounds, XXXIX. Alkenoxy(diorgany)boranes Substituted at the Alkeonxy Group from 2-methylacrolein and triorganylboranes,” Justus Liebigs Annalen Der Chemie, No. 06; pp. 1116-1134, (1976).
McMillin, et al., “Systemic Aspects of Psoriasis: An Intergrative Model Based on Intestinal Etiology”, Int. Med. vol. 2, Issue 2/3, (1999).
Moeder, et al., “Kinetic Analysis of the Asymmetric Amplification exhibited by B-chlorodiisopinocampheylborane,” Journal of Physical Organic Chemistry, vol. 17, No. 4; pp. 317-324, (Apr. 2004).
Morissette, et al., “High-throughput Crystallization: Polymorphs, Salts, Co-Crystals and Solvates of Pharmaceutical Solids”, Advanced Drug Delivery Reviews, vol. 56; pp. 273-300, (2004).
Patani, et al., “Bioterrorism: A Rational Approach to Drug Design”, Chem. Rev., vol. 96; pp. 3147-3176 (1996).
Qin, et al., “Luminescent Organoboron Quinolate Polymers,” Journal of the American Chemical Society, vol. 126, No. 22; pp. 7015-7018, (Jun. 9, 2004).
Rock, et al., “An Antifungal Agents Inhibits Aminoacyl-tRNA Synthetase by Trapping tRNA in the Editing

Affiliated with

Also associated with

Rating

Boron-containing small molecules as anti-inflammatory agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Boron-containing small molecules as anti-inflammatory agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Boron-containing small molecules as anti-inflammatory agents will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4280905